Posted by Michael Wonder on 04 Jan 2019
Third biological treatment gives more choice for people with severe asthma
4 January 2019 - Another potentially life-changing treatment should be available to people with a severe form of asthma, NICE says.
Draft guidance published today says that benralizumab is cost-effective for use on the NHS in England and Wales by some adults who have severe eosinophilic asthma and have struggled to control it with inhalers.
This uncommon and relatively uninvestigated form of asthma is believed to affect around 100,000 people in the UK.
